The reporting sensitivities of two passive surveillance systems for vaccine adverse events.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 1615747)

Published in Am J Public Health on December 01, 1995

Authors

S Rosenthal1, R Chen

Author Affiliations

1: National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.

Articles citing this

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92

Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis (2001) 1.19

The complicated task of monitoring vaccine safety. Public Health Rep (1997) 1.19

Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc (2007) 1.14

Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures. Clin Orthop Relat Res (2012) 1.01

The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health (2002) 0.93

Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women--Taiwan, November 2009-August 2010. PLoS One (2011) 0.86

Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China. Clin Vaccine Immunol (2012) 0.84

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010. Hum Exp Toxicol (2012) 0.84

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine (2015) 0.81

Product review on the JE vaccine IXIARO. Hum Vaccin Immunother (2015) 0.75

Swine flu: lessons we need to learn from our global experience. Emerg Health Threats J (2011) 0.75

Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System. Hum Vaccin Immunother (2013) 0.75

Articles cited by this

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet (1983) 3.15

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA (1990) 2.82

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55

Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med (1991) 2.40

Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12

The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02

Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA (1992) 1.74

Risk of seizures after measles-mumps-rubella immunization. Pediatrics (1991) 1.43

Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics (1988) 1.39

Food and Drug Administration monitoring of adverse drug reactions. Am J Hosp Pharm (1986) 1.30

Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol (1990) 1.18

Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09

Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr (1993) 1.03

History of convulsions and use of pertussis vaccine. J Pediatr (1985) 0.91

Monitoring system for adverse events following immunization. Vaccine (1987) 0.86

Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience. Ann N Y Acad Sci (1995) 0.86

Post-vaccination symptoms following DTP and DT vaccination. Dev Biol Stand (1985) 0.82

Articles by these authors

(truncated to the top 100)

UMLS concept indexing for production databases: a feasibility study. J Am Med Inform Assoc (2001) 9.02

Organization of heterogeneous scientific data using the EAV/CR representation. J Am Med Inform Assoc (1999) 6.97

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet (2001) 6.67

Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage (2001) 4.48

GEM: a proposal for a more comprehensive guideline document model using XML. J Am Med Inform Assoc (2000) 4.46

Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04

Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci U S A (1980) 2.64

Primary structure of major outer membrane protein I of Escherichia coli B/r. Proc Natl Acad Sci U S A (1979) 2.60

The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg (2000) 2.56

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52

Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50

Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34

Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25

A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25

Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab (2009) 2.19

Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14

Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology (1999) 2.13

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med (1996) 2.11

The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06

Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus. Proc Natl Acad Sci U S A (1982) 2.06

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03

Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02

DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res (2000) 1.97

Radioimmunological screening method for specific membrane proteins. Anal Biochem (1979) 1.96

Interactions between two different inhibitory systems in the human motor cortex. J Physiol (2001) 1.91

An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86

A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology (1993) 1.83

Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J Biol Chem (1994) 1.82

TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81

Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA (1997) 1.78

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics (1997) 1.77

Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation (1995) 1.73

Complications of laparoscopic procedures after concentrated training in urological laparoscopy. J Urol (2001) 1.71

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther (1999) 1.67

Dextromethorphan decreases the excitability of the human motor cortex. Neurology (1998) 1.66

Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin (2009) 1.62

A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60

Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60

Involvement of the human subthalamic nucleus in movement preparation. Neurology (2003) 1.59

Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59

Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun (2001) 1.58

The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol (2001) 1.54

Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem (1987) 1.53

Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension (1995) 1.53

Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci U S A (1998) 1.53

The primary structure of protein L16 located at the peptidyltransferase center of Escherichia coli ribosomes. FEBS Lett (1976) 1.53

Inflammatory pseudotumor of the liver. Report of the fine needle aspiration cytologic findings in a case initially misdiagnosed as malignant. Acta Cytol (1989) 1.51

Root gravitropism: an experimental tool to investigate basic cellular and molecular processes underlying mechanosensing and signal transmission in plants. Annu Rev Plant Biol (2002) 1.51

Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci U S A (1998) 1.51

- cross-linking sites in human and bovine fibrin. Biochemistry (1971) 1.50

A single nuclease active site of the Escherichia coli RecBCD enzyme catalyzes single-stranded DNA degradation in both directions. J Biol Chem (2000) 1.49

A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev (1993) 1.48

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res (2004) 1.48

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial. Int J Clin Pract (2009) 1.47

Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial. Ann Oncol (2009) 1.45

Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43

Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther (2003) 1.42

The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr (2005) 1.41

Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation (2001) 1.41

Inhibitory influence of the ipsilateral motor cortex on responses to stimulation of the human cortex and pyramidal tract. J Physiol (1998) 1.40

Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells. J Dent Res (2005) 1.39

Children and international travel: immunizations. Pediatr Infect Dis J (1995) 1.39

The sequence determination of a protein in a micro scale: the sequence analysis of ribosomal protein L34 of Escherichia coli. Hoppe Seylers Z Physiol Chem (1976) 1.37

ARG1 (altered response to gravity) encodes a DnaJ-like protein that potentially interacts with the cytoskeleton. Proc Natl Acad Sci U S A (1999) 1.36

Stimulation over the human supplementary motor area interferes with the organization of future elements in complex motor sequences. Brain (1997) 1.34

Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 1.32

UV light emitting transparent conducting tin-doped indium oxide (ITO) nanowires. Nanotechnology (2011) 1.31

Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol (2007) 1.30

Prevalence of overweight and central adiposity is associated with percentage of indigenous ancestry among native Hawaiians. Int J Obes Relat Metab Disord (1999) 1.30

Crossed reduction of human motor cortex excitability by 1-Hz transcranial magnetic stimulation. Neurosci Lett (1998) 1.26

Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab (2009) 1.26

Host cell proteins binding to domain IV of the 5' noncoding region of poliovirus RNA. J Virol (1995) 1.26

Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci (1996) 1.25

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology (1999) 1.24

Root gravitropism: a complex response to a simple stimulus? Trends Plant Sci (1999) 1.24

Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene (2007) 1.23

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy. Br J Cancer (2007) 1.22

Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun (2006) 1.22

Suppression of the motor cortex by magnetic stimulation of the cerebellum. Exp Brain Res (2001) 1.20

Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J Biol Chem (1996) 1.20

Occurrence of methylated amino acids as N-termini of proteins from Escherichia coli ribosomes. J Mol Biol (1977) 1.20

Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol (1999) 1.19

Sb-induced phase control of InAsSb nanowires grown by molecular beam epitaxy. Nano Lett (2015) 1.19

A study of three techniques for time-space clustering in Hodgkin's disease. Stat Med (1984) 1.19

The complete nucleotide sequence of a novel Tobamovirus, Rehmannia mosaic virus. Arch Virol (2007) 1.18

Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res (1995) 1.17

Toll-like receptor alterations in myelodysplastic syndrome. Leukemia (2013) 1.16

Centrifugal force model for pedestrian dynamics. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 1.16

Controlling the phenotype and function of mesenchymal stem cells in vitro by adhesion to silane-modified clean glass surfaces. Biomaterials (2005) 1.16

A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect (2013) 1.14

Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol (1996) 1.13